Latest News about SRPT
Recent news which mentions SRPT
Why Sarepta Therapeutics' Shares Rose 23.4% This Week
March 02, 2023
From Motley Fool
3 Best Growth Stocks to Buy In March
March 02, 2023
From Motley Fool
Why Novavax Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
March 01, 2023
From Benzinga
3D Systems, CarGurus, Sarepta Therapeutics And Other Big Stocks Moving Higher On Wednesday
March 01, 2023
From Benzinga
From Benzinga
Why Is Sarepta Therapeutics (SRPT) Stock Up 21% Today?
March 01, 2023
From InvestorPlace
From Motley Fool
From Benzinga
Sarepta Therapeutics To Rally Over 53%? Here Are 10 Other Analyst Forecasts For Wednesday
March 01, 2023
From Benzinga
Why Reata Pharmaceuticals Shares Are Trading Higher By 140%; Here Are 20 Stocks Moving Premarket
March 01, 2023
From Benzinga
From InvestorPlace
Sarepta Therapeutics (SRPT) Q4 2022 Earnings Call Transcript
February 28, 2023
Tickers
SRPT
From Motley Fool
FDA approves Reata’s rare disease drug amid questions about changes to the regulatory environment for neuroscience treatments
February 28, 2023
From MarketWatch
12 Health Care Stocks Moving In Tuesday's After-Market Session
February 28, 2023
From Benzinga
Earnings Scheduled For February 28, 2023
February 28, 2023
From Benzinga
3 Gene Editing Stocks With the Best Long-Term Potential
January 25, 2023
From InvestorPlace
7 Biotech Stocks That Will Make You Rich in 10 Years
January 18, 2023
Tags
EXEL
INCY
NYSE:ABBV,NYSE:DIS,NYSE:PFE,NASDAQ:INCY,NASDAQ:EXEL,NASDAQ:CRSP,NASDAQ:VRTX,NASDAQ:SRPT,NASDAQ:CVAC
From InvestorPlace
2 Under-the-Radar Biotech Stocks to Buy in 2023
January 06, 2023
From Motley Fool
2 Top Healthcare Stocks to Buy for the Long Haul
December 09, 2022
From Motley Fool
Sarepta Therapeutics (SRPT) Q3 2022 Earnings Call Transcript
November 03, 2022
Tickers
SRPT
From Motley Fool
Earnings Scheduled For November 2, 2022
November 02, 2022
From Benzinga
3 Unstoppable Stocks That Could Double in 5 Years
October 29, 2022
From Motley Fool
2 Under-the-Radar Biotech Stocks to Buy in 2022
October 19, 2022
From Motley Fool
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.